Jazz Pharmaceuticals plc
JAZZ
$103.58
$5.805.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -533.06% | 102.98% | 46.48% | 61.40% | -121.06% |
| Total Depreciation and Amortization | 0.91% | 5.79% | 1.64% | 2.17% | 3.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.06% | 25.25% | 100.50% | -46.84% | -17.91% |
| Change in Net Operating Assets | 410.47% | 55.84% | -7.47% | -55.79% | 207.79% |
| Cash from Operations | 60.83% | 138.19% | 29.80% | 11.65% | -16.68% |
| Capital Expenditure | -101.06% | -31.53% | -150.94% | -23.56% | -80.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.49% | -260.86% | 232.28% | -212.50% | -26,400.00% |
| Cash from Investing | 37.87% | -289.87% | 222.83% | -199.85% | -5,538.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9,677.42% | 0.00% | -7,419.35% | 0.00% | 0.00% |
| Issuance of Common Stock | 2,217.21% | 3.87% | -99.69% | 0.68% | -97.67% |
| Repurchase of Common Stock | -36.24% | 96.05% | -98.81% | -64.63% | -13.94% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,338.44% | 91.75% | 413.95% | -66.64% | -89.85% |
| Foreign Exchange rate Adjustments | 199.82% | -227.95% | 401.97% | -2,332.35% | -612.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -775.52% | 14.13% | 1,515.28% | -176.56% | -121.97% |